Mark Mallon - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Executive Officer, Director
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:59:06 UTC
Previous filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +142,457 +63% $0.000000 368,051 01 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +347,777 $0.000000 347,777 01 Mar 2022 Common Stock 347,777 $21.41 Direct F3
holding NEO Stock Option (Right to Buy) 151,016 01 Mar 2022 Common Stock 151,016 $49.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Limited Power Of Attorney